GNH USA

Europe — EMA

Leuprorelin Sandoz

GNH USA supplies Leuprorelin Sandoz (Leuprorelin), a Gonadotropin‑releasing hormone agonist for prostate cancer, endometriosis and related hormone‑dependent

Leuprorelin

Request sourcing

1
Pack/s

What is Leuprorelin?

Leuprorelin, the active ingredient in Leuprorelin Sandoz, is a Gonadotropin‑releasing hormone agonist presented as a sterile solution for subcutaneous use. It is employed in hormone‑dependent conditions such as prostate cancer, endometriosis, uterine fibroids, precocious puberty, and certain breast cancers. GNH USA supplies Leuprorelin Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

What is Leuprorelin used for?

Leuprorelin acts on the GnRH pathway to suppress sex‑hormone production in several hormone‑driven diseases. - Prostate cancer: lowers testosterone to inhibit tumor progression. - Endometriosis: reduces estrogen‑driven pelvic tissue growth. - Uterine fibroids: diminishes fibroid size by limiting ovarian hormone stimulation. - Precocious puberty: delays early sexual development by suppressing gonadotropins. - Breast cancer: decreases estrogen levels in hormone‑sensitive tumors.

What are the side effects of Leuprorelin?

Leuprorelin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Hot flashes: transient warmth and sweating. - Injection site reactions: redness, pain, or swelling. - Headache: mild to moderate intensity. - Fatigue: general tiredness. - Nausea: occasional upset stomach. - Decreased libido: reduced sexual desire.

Serious or Rare Side Effects: - Bone loss: increased risk of osteoporosis. - Cardiovascular events: rare cases of myocardial infarction or stroke. - Severe allergic reaction: anaphylaxis, rash, or angioedema. - Adrenal insufficiency: impaired cortisol production. - Pituitary apoplexy: sudden hemorrhage within the pituitary gland.

What precautions apply to Leuprorelin?

Before initiating therapy, clinicians should evaluate patient‑specific risk factors. - Cardiovascular disease: assess risk and monitor closely. - Bone health: perform baseline bone density testing and consider supplementation. - Diabetes mellitus: monitor glucose levels regularly. - Pregnancy and lactation: avoid unless clearly indicated, as safety is unknown. - Drug interactions: review concomitant medications for potential effects. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Leuprorelin interact with?

Leuprorelin can interact with several medication classes; awareness helps prevent reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Estrogen therapy: may counteract hormone suppression. - GnRH antagonists: opposing mechanisms can diminish therapeutic effect. - Hormone replacement therapy: can interfere with intended hormone down‑regulation.

Moderate Interactions (Monitor Closely): - Anticoagulants: potential for altered bleeding risk. - Glucocorticoids: may exacerbate bone‑loss concerns. - Bisphosphonates: concurrent use may mask bone‑density changes.

Frequently asked questions

What conditions is Leuprorelin Sandoz used to treat?+
Leuprorelin Sandoz is prescribed for hormone‑dependent diseases such as prostate cancer, endometriosis, uterine fibroids, precocious puberty, and certain estrogen‑sensitive breast cancers. By suppressing sex‑hormone production, it helps control disease progression and related symptoms.
How does leuprorelin work in the body?+
Leuprorelin mimics natural GnRH, initially stimulating pituitary release of LH and FSH. Continuous exposure leads to down‑regulation of GnRH receptors, sharply reducing LH and FSH secretion and consequently lowering the production of testosterone and estrogen, which fuels many hormone‑driven conditions.
What is the usual dose of Leuprorelin Sandoz?+
The specific dose and dosing schedule of Leuprorelin Sandoz are determined by the prescribing clinician based on the patient’s condition, disease severity, and treatment goals. Healthcare providers tailor the regimen to achieve optimal hormone suppression while minimizing side effects.
Is Leuprorelin Sandoz safe during pregnancy or breastfeeding?+
Safety of leuprorelin in pregnancy and lactation has not been established. It is generally avoided in pregnant or nursing women unless the potential benefit outweighs the potential risk, and it should only be used under strict medical supervision.
How do I order Leuprorelin Sandoz from GNH USA?+
To request Leuprorelin Sandoz, submit an enquiry on the product page at gnh-usa.com with the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.
How does Leuprorelin compare with other hormone‑therapy options?+
Leuprorelin is a GnRH agonist that provides profound and sustained suppression of sex hormones, often achieving greater hormonal control than oral anti‑androgens or estrogen blockers. Compared with GnRH antagonists, it may have a brief initial hormone surge but is widely used due to its established efficacy and dosing flexibility.
What are the storage and handling requirements for Leuprorelin Sandoz?+
Leuprorelin Sandoz should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. Keep the product in its original packaging until use to maintain stability and potency.
How is Leuprorelin Sandoz administered?+
Leuprorelin Sandoz is given by subcutaneous injection, typically into the abdomen or thigh. The injection is performed by a qualified healthcare professional using aseptic technique, and the site should be rotated to reduce local irritation.
What are the most serious risks associated with Leuprorelin Sandoz?+
Serious risks include significant bone loss leading to osteoporosis, rare cardiovascular events such as heart attack or stroke, severe allergic reactions (anaphylaxis), and adrenal insufficiency. Patients should be monitored regularly for these complications, especially during long‑term therapy.
Who should not use Leuprorelin Sandoz?+
Leuprorelin Sandoz is contraindicated in individuals with known hypersensitivity to leuprorelin or any formulation components. It should also be avoided in patients with uncontrolled cardiovascular disease, severe osteoporosis, or those who are pregnant or breastfeeding unless absolutely necessary.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Leuprorelin
Route
Subcutaneous Use
Manufacturer
Sandoz A/S
Origin
EU

Related products

Camcevi

Camcevi

Leuprorelin

Accord Healthcare S.L.U.
EU
Camcevi

Camcevi

Leuprorelin

Accord Healthcare S.L.U.
EU
Camcevi

Camcevi

Leuprorelin

Accord Healthcare S.L.U.
EU
Camcevi

Camcevi

Leuprorelin

Accord Healthcare S.L.U.
EU